Direct delivery of an investigational cell therapy in patients with Parkinson's disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design.
Jorge E QuinteroJohn T SlevinJulie A GurwellChristopher J McLouthRiham El KhouliMonica J ChauZain GuduruGreg A GerhardtCraig G van HornePublished in: BMJ neurology open (2022)
NCT02369003.